JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 5 No. 12 895-900
© 1964 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spencer, R. P.
Right arrow Articles by Flanigan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, R. P.
Right arrow Articles by Flanigan, S.

Peripheral Appearance of Radiolabeled Albumin and an Alkylating Agent During Regional Brain Perfusion1

Richard P. Spencer, M.D., Ph.D., James B. D. Mark, M.D. and Stevenson Flanigan, M.D.2

New Haven, Connecticut

ABSTRACT

During a regional brain perfusion, albumin-131I added to the perfusing fluid rapidly decreased in activity and appeared in the peripheral circulation. When triethylene thiophosphoramide-S35 was present in the perfusing fluid, about 14 per cent appeared in the peripheral circulation within one minute. The concentration of radioactivity in the perfusing fluid, as a function of time, was described by an hyperbola. These results cast doubt on the efficacy of carrying regional brain perfusion beyond four or five minutes.

FOOTNOTES

1 Supported by USPHS Research Grants Nos. CA 6519 and HD 00411.

2 From the Departments of Radiology and Surgery, Yale University School of Medicine, New Haven, Connecticut.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1964 by the Society of Nuclear Medicine.